SecBot SecBot
8-K ·Filed Aug 17, 2026

ARDX

ARDELYX, INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed2mo ago SEC0001193125-26-354026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for the appointment of a new Chief Commercial Officer and any potential impact on commercial execution. The resignation is routine and lacks material financial details, so no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
ARDX ▼ -13.27% at T+20d
NEUTRAL call -13.27% · α vs SPY -12.28% · entry $3.92 → $3.40
Next anchor: T+60d in 13d
Latest observation: T+47 +21.98% FF3 residual α
Entry = T+0 close
Aug 17, 2026
via day close
T+1d
+2.81%
call +2.81% · α +2.60%
$4.03
settled 2mo ago
T+5d
-3.57%
call -3.57% · α -3.37%
$3.78
settled 2mo ago
T+20d
-13.27%
call -13.27% · α -12.28%
$3.40
settled 6w ago
T+60d
Pending
in 13d

Price Chart

Loading chart...

Executive Summary

Ardelyx disclosed the resignation of Chief Commercial Officer Eric Foster, effective August 28, 2026, to pursue a new opportunity at a pre-commercial company. The departure is a routine executive transition with no disagreement cited, and no financial details or commercial impact were provided. This filing is administrative in nature and lacks material financial or operational information.

Key Facts

  • Chief Commercial Officer Eric Foster resigned effective August 28, 2026.
  • Resignation is to pursue a new opportunity at a pre-commercial company.
  • The filing states the resignation is not due to any disagreement with the company.
  • No financial figures, commercial impact, or successor information were disclosed.

Financial Impact

No financial impact disclosed or estimable from the filing.

Risk Factors

  • Potential disruption to commercial strategy if a successor is not named promptly.
  • No disclosed financial impact, but loss of a key commercial executive could affect near-term execution.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-354026
Document: 0001193125-26-354026-index-headers.html0001193125-26-354026
Document: 0001193125-26-354026-index.html0001193125-26-354026
Document: 0001193125-26-354026.txt0001193125-26-354026
16 reports for ARDX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARDX — sortable, filterable
TypeNow
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$3.39awaiting T+20—$3.00 (−11.50%)
Aug 25, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.83 $3.45▼ −9.92%▼ −10.15%$3.00 (−21.67%)
Aug 25, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.83 $3.45▼ −9.92%▼ −10.15%$3.00 (−21.67%)
Aug 21, 2026
9w ago
144
NEUTRAL ★ 2/10
$3.74 $3.62▼ −3.21%▼ −4.52%$3.00 (−19.79%)
Aug 21, 2026
9w ago
144
NEUTRAL ★ 2/10
$3.74 $3.62▼ −3.21%▼ −4.52%$3.00 (−19.79%)
Aug 17, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$3.92 $3.40▼ −13.27%▼ −12.28%$3.00 (−23.47%)
Aug 15, 2026
10w ago
Institutional Cluster
BULLISH ★ 4/10
$4.06 $3.52▼ −13.30%▼ −11.77%$3.00 (−26.11%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$5.27 $5.04▼ −4.36%▼ −3.95%$3.00 (−43.07%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$6.05 $5.13▼ −15.29%▼ −15.82%$3.00 (−50.41%)
Jun 15, 2026
19w ago
144
NEUTRAL ★ 3/10
$5.67 $5.16▼ −8.99%▼ −9.19%$3.00 (−47.09%)
Showing 10 of 16

US Market Status

Market Closed — Opens Thu (11h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026